Literature DB >> 12815058

Role of human sphingosine-1-phosphate phosphatase 1 in the regulation of intra- and extracellular sphingosine-1-phosphate levels and cell viability.

Korey R Johnson1, Kristy Y Johnson, Kevin P Becker, Jacek Bielawski, Cungui Mao, Lina M Obeid.   

Abstract

Sphingosine-1-phosphate (S1P) is a highly bioactive lipid that exerts numerous biological effects both intracellularly as a second messenger and extracellularly by binding to its G-protein-coupled receptors of the endothelial differentiation gene family (S1P receptors-(1-5)). Intracellularly, at least two enzymes, sphingosine kinase and S1P phosphatase, regulate the activity of S1P by governing the phosphorylation status of S1P. To study the regulation of S1P levels, we cloned the human isoform of S1P phosphatase 1 (hSPPase1). The hSPPase1 has 78% homology to the mouse SPPase at the amino acid level with 6-8 possible transmembrane domains. Confocal microscopy revealed green fluorescent protein-tagged hSPPase1, expressed in either MCF7 or HEK293 cells, co-localized to endoplasmic reticulum with calreticulin. According to Northern blot analysis, hSPPase1 is expressed in most tissues, with the strongest levels found in the highly vascular tissues of placenta and kidney. Transient overexpression of hSPPase1 exhibited a 2-fold increase in phosphatase activity against S1P and dihydro-S1P, indicating that the expressed protein was functional. Small interfering RNA (siRNA) knockdown of endogenous hSPPase1 drastically reduced hSPPase1 mRNA levels, as confirmed by reverse transcription PCR, and resulted in an overall 25% reduction of in vitro phosphatase activity in the membrane fractions. Sphingolipid mass measurements in hSPPase1 siRNA knockdown cells revealed a 2-fold increase of S1P levels and concomitant decrease in sphingosine. In vivo labeling of hSPPase1 siRNA-treated cells showed accumulation of S1P within cells, as well as significantly increased secretion of S1P into the media, indicating that hSPPase1 regulates secreted S1P. In addition, siRNA-induced knockdown of hSPPase1 endowed resistance to tumor necrosis factor-alpha and the chemotherapeutic agent daunorubicin. Collectively, these data suggest that regulation of hSPPase1 with the resultant changes in cellular and secreted S1P could have important implications to cell proliferation, angiogenesis, and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12815058     DOI: 10.1074/jbc.M301741200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

Review 1.  Shaping the landscape: metabolic regulation of S1P gradients.

Authors:  Ana Olivera; Maria Laura Allende; Richard L Proia
Journal:  Biochim Biophys Acta       Date:  2012-06-23

Review 2.  Regulation and functional roles of sphingosine kinases.

Authors:  Regina Alemany; Chris J van Koppen; Kerstin Danneberg; Michael Ter Braak; Dagmar Meyer Zu Heringdorf
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-23       Impact factor: 3.000

3.  Role of sphingosine-1-phosphate phosphohydrolase 1 in the regulation of resistance artery tone.

Authors:  Bernhard Friedrich Peter; Darcy Lidington; Aki Harada; Hanno Jörn Bolz; Lukas Vogel; Scott Heximer; Sarah Spiegel; Ulrich Pohl; Steffen-Sebastian Bolz
Journal:  Circ Res       Date:  2008-06-26       Impact factor: 17.367

Review 4.  PLP-dependent enzymes as entry and exit gates of sphingolipid metabolism.

Authors:  Florence Bourquin; Guido Capitani; Markus Gerhard Grütter
Journal:  Protein Sci       Date:  2011-09       Impact factor: 6.725

5.  A novel method to quantify sphingosine 1-phosphate by immobilized metal affinity chromatography (IMAC).

Authors:  Yong-Moon Lee; Krishnan Venkataraman; Sun-Il Hwang; David K Han; Timothy Hla
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-08-06       Impact factor: 3.072

6.  Sphingolipid signaling and treatment during remodeling of the uninfarcted ventricular wall after myocardial infarction.

Authors:  Che-Chung Yeh; Hongzhe Li; Deepak Malhotra; Mei-Chuan Huang; Bo-Qing Zhu; Edward J Goetzl; Donald A Vessey; Joel S Karliner; Michael J Mann
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-20       Impact factor: 4.733

7.  Production of nerve growth factor enhanced in cultured mouse astrocytes by glycerophospholipids, sphingolipids, and their related compounds.

Authors:  Atsushi Furukawa; Kouzou Kita; Misao Toyomoto; Shinobu Fujii; Seiji Inoue; Kyozo Hayashi; Kiyoshi Ikeda
Journal:  Mol Cell Biochem       Date:  2007-06-19       Impact factor: 3.396

8.  Dynamic regulation of sphingosine-1-phosphate homeostasis during development of mouse metanephric kidney.

Authors:  R Jason Kirby; Ying Jin; Jian Fu; Jimena Cubillos; Debi Swertfeger; Lois J Arend
Journal:  Am J Physiol Renal Physiol       Date:  2008-12-10

Review 9.  Sphingolipids in mitochondria.

Authors:  María José Hernández-Corbacho; Mohamed F Salama; Daniel Canals; Can E Senkal; Lina M Obeid
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-09-30       Impact factor: 4.698

Review 10.  Targeting sphingosine-1-phosphate signaling in lung diseases.

Authors:  David L Ebenezer; Panfeng Fu; Viswanathan Natarajan
Journal:  Pharmacol Ther       Date:  2016-09-13       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.